Peripheral blood mononuclear cells (PBMCs) from therapy-naive RA patients showed low Pgp levels ex vivo; however, its expression could compromise the inhibitory effect of carfilzomib and ONX-0914, which could be significantly reduced by a Pgp transport inhibitor P121 (reversin 121) [96]. Here, PGP is linked to rheumatoid arthritis.